PCR Test Comparison Reveals Hidden Burden of Cattle Anaplasmosis in Venezuela

A tick-borne bacterium that quietly saps the productivity of cattle herds across the tropics has been put under a new molecular spotlight in Venezuela. Researchers reporting in Acta Parasitologica have compared two polymerase chain reaction strategies for detecting Anaplasma marginale, the causative agent of bovine anaplasmosis, in cattle from the country’s central region, and their findings carry a double message: the standard diagnostic target remains the most reliable choice for routine surveillance, yet the true scale of infection in apparently healthy animals is far larger than clinical observation alone would suggest.

Anaplasma marginale is an obligate intracellular bacterium of the family Anaplasmataceae that infects the red blood cells of cattle. The disease it causes ranges from severe, sometimes fatal hemolytic anemia in acute cases to persistent, lifelong carriage in animals that never show overt signs of illness. These persistently infected carriers act as silent reservoirs, sustaining transmission cycles through tick vectors and through mechanical transfer of contaminated blood on needles or dehorning equipment. Because carrier animals are the epidemiological engine of the disease, accurate detection of low-level infections is central to any control program, and molecular methods such as PCR have become the reference standard for that purpose.

The research team, led by Mariana Carolina Eleizalde of the Universidad Nacional Experimental Simón Rodríguez together with colleagues from institutions in Venezuela, Ecuador and Spain, set out to explore whether primers targeting the msp2 gene could serve as an alternative to the widely used 19A/19B primer pair, which amplifies the single-copy msp5 gene. The rationale was straightforward: msp2 exists as a multicopy gene family in the A. marginale genome, and a higher template copy number can, in principle, improve the analytical sensitivity of a PCR assay. The msp2 gene family encodes major surface protein 2, a key antigen that the bacterium uses for antigenic variation, allowing it to evade the bovine immune response and persist indefinitely in the host.

To test this idea, the investigators standardized PCR conditions for a primer set, designated msp2A/B, designed to bind conserved terminal regions of the msp2 gene, and then evaluated its analytical sensitivity alongside the reference 19A/19B set. Both primer sets proved capable of detecting pathogen DNA at concentrations as low as 0.01 nanograms, indicating comparable analytical sensitivity under controlled laboratory conditions. On paper, the multicopy target looked like a promising candidate for field deployment. The decisive test, however, would come from real-world samples drawn from cattle herds in the Venezuelan countryside.

The field component of the study involved 208 cattle from small farms in four geographically distinct regions of Venezuela: Aragua, Cojedes, Guárico and Miranda. The animals were divided into two groups with different clinical characteristics, allowing the researchers to assess diagnostic performance both during an active disease outbreak and in clinically normal stock. In a herd of 24 cattle experiencing an anaplasmosis outbreak, the divergence between the two assays was striking. Primers msp2A/B detected the pathogen in only 12.5 percent of the animals, while the msp5-targeting 19A/19B primers returned positive results in 66.67 percent of the same herd, a more than fivefold difference in apparent positivity.

To understand why the multicopy target underperformed despite its theoretical sensitivity advantage, the team cloned and sequenced one of the positive amplicons obtained with the msp2A/B primers. Sequencing confirmed the bacterial identity of the product, yielding a 97 percent BLAST identity with complete coverage to the reference strain Florida. But the sequence also revealed something important: 10 nucleotide substitutions were present at the 5-prime end and 5 at the 3-prime end of the amplified region compared with the reference isolate. This terminal heterogeneity in the msp2 gene suggests that mismatches between the primers and the local Venezuelan strain’s DNA could compromise amplification efficiency, providing a plausible molecular explanation for the reduced diagnostic performance observed in the field.

Beyond its diagnostic implications, the sequence itself represents a milestone. The study constitutes the first report of an msp2 sequence from a Venezuelan A. marginale isolate, and the sequence has been deposited in GenBank under accession number MT969021. Given that msp2 is central to the bacterium’s antigenic variation machinery, having sequence data from a local isolate offers preliminary insight into the genetic diversity of A. marginale in Venezuela, a country where recent molecular reports on the pathogen have been scarce. Such data are relevant not only for diagnostics but also for understanding how regional strains may differ in the surface proteins that vaccines and immune responses must confront.

The epidemiological findings from the clinically healthy portion of the sample were equally consequential. When 184 clinically normal cattle were analyzed using the 19A/19B primers alone, the researchers found a subclinical prevalence of 41.85 percent. In other words, more than four in ten animals that appeared healthy were carrying detectable levels of the bacterium. This figure underscores the epidemiological relevance of persistent infections in Venezuelan herds and highlights the risk that carrier animals pose as reservoirs for onward transmission, whether through tick bites or through iatrogenic routes such as shared needles during routine husbandry and vaccination campaigns.

The study’s conclusions point clearly toward msp5-based PCR as the preferred tool for routine field detection and surveillance in Venezuela. The single-copy msp5 gene is known to be highly conserved across recognized Anaplasma species, which likely explains why primers targeting it remained robust against the sequence variability that undermined the msp2 assay. The result is a useful reminder of a broader principle in molecular diagnostics: analytical sensitivity measured on purified templates does not always translate into diagnostic sensitivity in the field, where genetic diversity in the target region can silently erode assay performance. Primer design for variable gene families demands either conserved anchor sites or degenerate bases that accommodate local sequence diversity.

For a country with limited recent molecular surveillance data on bovine hemoparasites, the study fills an important gap and provides a foundation for future work. The combination of a validated, field-tested diagnostic protocol, a newly reported msp2 sequence, and quantified subclinical prevalence gives Venezuelan veterinary authorities and producers concrete tools for monitoring anaplasmosis in smallholder systems, where the disease imposes a persistent drag on livestock productivity. As climate change alters the distribution of tick vectors such as Rhipicephalus microplus across Latin America, the need for reliable, locally validated molecular surveillance of A. marginale will only grow, making studies of this kind an essential first step toward evidence-based control of one of the region’s most economically significant cattle diseases.

Subject of Research: Molecular detection and epidemiology of the tick-borne cattle pathogen Anaplasma marginale in Venezuela using PCR assays targeting the msp2 and msp5 genes

Article Title: Molecular Detection of Anaplasma marginale in the Central Region of Venezuela: A PCR-based Assessment of the msp2 and msp5 Genes

Article References: Molecular Detection of Anaplasma marginale in the Central Region of Venezuela: A PCR-based Assessment of the msp2 and msp5 Genes. (n.d.). https://doi.org/10.1007/s11686-026-01413-y

Image Credits: AI Generated

DOI: 10.1007/s11686-026-01413-y

Keywords: Anaplasma marginale, bovine anaplasmosis, PCR, msp2, msp5, Venezuela, molecular diagnostics, cattle, tick-borne disease, epidemiology, subclinical infection, genetic diversity